Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-04-06

FDA Approved: DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE — Original Application (Novadoz Pharmaceuticals LLC)

View source ↗

Summary

FDA approved a combination tablet of dapagliflozin and metformin hydrochloride under an original ANDA from Novadoz Pharmaceuticals LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dapagliflozin and metformin hydrochloride (dapagliflozin and metformin hydrochloride)

Snippet

ORIG AP for DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE (DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE)